TO ACHIEVE MAXIMUM RESULTS, IT IS RECOMMENDED THAT PATIENTS BEGIN TREATMENT WITH PRESCRIPTION STRENGTH DERMAZINC™. FOR ADDITIONAL INFORMATION, ASK A HEALTH CARE PROFESSIONAL.
Dermalogix Partners, Inc. patented formulation of medicated DermaZinc™ Spray/Drops is the original topical zinc pyrithione treatment for chronic skin conditions. By combining (0.25%) zinc pyrithione with isopropyl myristate, Dermalogix Partners has created in DermaZinc™ Spray/Drops one of the most effective anti-itching, anti-flaking, anti-fungal agents available for treating skin disorders sold over the counter (OTC). Please note, DermaZinc™ OTC Spray/Drops is not recommended for children under the age of 12, unless directed by a doctor.
IMPORTANT: Patients suffering with severe cases of eczema, psoriasis and seborrheic dermatitis, the use of prescription strength DermaZinc™ Spray/Drops is recommended. DermaZinc™Spray/Drops compounded with 64mg of Micronized Betamethasone Diproprionate USP prescribed by your doctor, used twice daily for up to two weeks. Once skin is cleared, maintain healthy skin by using OTC DermaZinc™ products a minimum of three times per week.
Pharmacist and Doctors, please see compounding instructions or call 1-800-753-0047 for more information. To achieve maximum results, Micronized Powder Betamethasone Diproprionate USP should be used.
For additional product information, usage and product warnings, click here.